NewGenIVF prices $1.3M offering to fund AI, crypto and IVF pivot

What's the deal? NewGenIvf GroupDealroom has a profile for this one. Try Dealroom →, a Nasdaq-listed company (NIVF), has priced a public offering expected to raise about $1.25 million in gross proceeds. The deal covers 17,857,143 ordinary shares — or pre-funded warrants in lieu — at $0.07 per share. It is set to close on or about September 30, 2026.

Who's involved? Aegis Capital Corp.Dealroom has a profile for this one. Try Dealroom → is acting as exclusive placement agent for the offering, made on a reasonable best efforts basis.

What's the money for? NewGen plans to use net proceeds, alongside existing cash, for investment in K25.aiDealroom has a profile for this one. Try Dealroom →, restructuring debt securities, and working capital — including manufacturing and deploying Nodexus machines in its cell-sorting business.

What's the endgame? Once an IVF and assisted reproduction provider across Asia, NewGen now describes itself as a diversified group spanning real estate, digital assets and health. It operates through NewGenPropertyDealroom has a profile for this one. Try Dealroom →, focused on projects in the UAE's Ras Al Khaimah Emirate; NewGenDigitalDealroom has a profile for this one. Try Dealroom →, targeting decentralised finance; and NewGenSupDealroom has a profile for this one. Try Dealroom →, selling longevity products.

Why now? The registration statement was declared effective by the Securities and Exchange Commission on September 28, 2026, after being filed on August 20. This small, fast-moving raise points to a company topping up capital as it stretches across multiple new sectors.

The signal: A $1.25 million raise at $0.07 a share is a modest lifeline, not a war chest. For a former IVF specialist now chasing AI, crypto and property, the offering underscores how far — and how fast — NewGen is trying to reinvent itself.

Read more: pr.sacramentooracle.com

Image credit: Generated with Gemini